FormWeb • candesartan

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

candesartan

candesartan

Restricted Angiotensin II Receptor Antagonist Formulary
Restricted Atacand --> Restricted to NO SUB orders.
Therapeutic Interchange

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Atacand	TABLET, ORAL	4 mg, 8 mg, 16 mg, 32 mg

VIEW MORE Angiotensin II Receptor Antagonists
CLASS

Comments:

ORDERED FORMULATION

FORMULARY INTERCHANGE

NOTES

candesartan (Atacand)*

4 mg
8 mg
16 mg

losartan (Cozaar)

25 mg
50 mg
100 mg

Note that 32 mg dose is converted to valsartan

*If ordered twice daily, convert total daily dose to losartan equivalent and give ONCE DAILY.

For dosage conversions higher than 32 mg per day, contact the physician and discuss dosing (generally, there is little additional benefit from higher doses than those specified)

candesartan (Atacand)*

32 mg

valsartan (Diovan)

valsartan (Diovan) 320 mg

Reviewed: April 27, 2010.

Last updated: Nov. 7, 2018

Black Box Warning: Candesartan: pregnancy risk
Formulary, Not Routinely Stocked:

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.